Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Management of the small renal mass.

Almassi N, Gill BC, Rini B, Fareed K.

Transl Androl Urol. 2017 Oct;6(5):923-930. doi: 10.21037/tau.2017.07.11. Review.

2.

Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups Among Individuals With Early-Stage Kidney Cancer.

Egleston BL, Uzzo RG, Wong YN.

J Am Stat Assoc. 2017;112(518):534-546. doi: 10.1080/01621459.2016.1240078. Epub 2016 Oct 7.

3.

Delayed Intervention of Small Renal Masses on Active Surveillance.

Gupta M, Blute ML Jr, Su LM, Crispen PL.

J Kidney Cancer VHL. 2017 May 24;4(2):24-30. doi: 10.15586/jkcvhl.2017.75. eCollection 2017.

4.

Decision Making: Thermal Ablation Options for Small Renal Masses.

McCarthy CJ, Gervais DA.

Semin Intervent Radiol. 2017 Jun;34(2):167-175. doi: 10.1055/s-0037-1602708. Epub 2017 Jun 1. Review.

PMID:
28579684
5.

Expanding thermal ablation to the 'intermediate-sized' renal mass: clinical utility in T1b tumors.

Schulman AA, Tay KJ, Polascik TJ.

Transl Androl Urol. 2017 Feb;6(1):127-130. doi: 10.21037/tau.2017.01.08. No abstract available.

6.

Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends.

Farrag K, Sriprasad S.

Indian J Surg Oncol. 2017 Mar;8(1):39-45. doi: 10.1007/s13193-016-0598-x. Epub 2016 Dec 15. Review.

7.

Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data.

Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Morgan TM, Kim SP, Malhotra A, Handorf E, Wong YN, Uzzo RG, Kutikov A.

Med Care. 2017 Apr;55(4):398-404. doi: 10.1097/MLR.0000000000000657.

8.

Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation.

Lee HJ, Chung HJ, Wang HK, Shen SH, Chang YH, Chen CK, Chou HP, Chiou YY.

Br J Radiol. 2016 Sep;89(1065):20160151. doi: 10.1259/bjr.20160151. Epub 2016 Jul 12.

9.

Renal Tumor Biopsy Technique.

Zhang L, Li XS, Zhou LQ.

Chin Med J (Engl). 2016 May 20;129(10):1236-40. doi: 10.4103/0366-6999.181957. Review.

10.

Challenges in RCC Imaging: Renal Insufficiency, Post-Operative Surveillance, and the Role of Radiomics.

Farber NJ, Wu Y, Zou L, Belani P, Singer EA.

Kidney Cancer J. 2015 Nov;13(4):84-90. No abstract available.

11.

Incidental vs symptomatic renal tumours: Survival outcomes.

Al-Marhoon MS, Osman AM, Kamal MM, Shokeir AA.

Arab J Urol. 2011 Mar;9(1):17-21. doi: 10.1016/j.aju.2011.03.006. Epub 2011 May 6.

12.

The role of biopsy in incidental renal tumours.

Al-Marhoon MS.

Arab J Urol. 2011 Mar;9(1):11-5. doi: 10.1016/j.aju.2011.03.005. Epub 2011 May 6. Review.

13.

Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?

Mehrazin R, Smaldone MC, Egleston B, Tomaszewski JJ, Concodora CW, Ito TK, Abbosh PH, Chen DY, Kutikov A, Uzzo RG.

Urol Oncol. 2015 Apr;33(4):167.e7-12. doi: 10.1016/j.urolonc.2015.01.013. Epub 2015 Mar 14.

14.

Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.

Chen F, Huhdanpaa H, Desai B, Hwang D, Cen S, Sherrod A, Bernhard JC, Desai M, Gill I, Duddalwar V.

Springerplus. 2015 Feb 10;4:66. doi: 10.1186/s40064-015-0823-z. eCollection 2015.

15.

A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures.

Egleston BL, Uzzo RG, Beck JR, Wong YN.

Health Serv Res. 2015 Aug;50(4):1179-94. doi: 10.1111/1475-6773.12276. Epub 2014 Dec 18.

16.

Current status of cryotherapy for prostate and kidney cancer.

Cho S, Kang SH.

Korean J Urol. 2014 Dec;55(12):780-8. doi: 10.4111/kju.2014.55.12.780. Epub 2014 Nov 21. Review.

17.

Patient and tumor characteristics can predict nondiagnostic renal mass biopsy findings.

Prince J, Bultman E, Hinshaw L, Drewry A, Blute M, Best S, Lee FT Jr, Ziemlewicz T, Lubner M, Shi F, Nakada SY, Abel EJ.

J Urol. 2015 Jun;193(6):1899-904. doi: 10.1016/j.juro.2014.12.021. Epub 2014 Dec 11.

18.

Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Rendon RA, Kapoor A, Breau R, Leveridge M, Feifer A, Black PC, So A.

Can Urol Assoc J. 2014 May;8(5-6):E398-412. doi: 10.5489/cuaj.1894. No abstract available.

19.

Pathological characteristics and radiographic correlates of complex renal cysts.

Reese AC, Johnson PT, Gorin MA, Pierorazio PM, Allaf ME, Fishman EK, Netto GJ, Pavlovich CP.

Urol Oncol. 2014 Oct;32(7):1010-6. doi: 10.1016/j.urolonc.2014.02.022. Epub 2014 Jul 9.

20.

Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesions.

Tomaszewski JJ, Uzzo RG, Kocher N, Li T, Manley B, Mehrazin R, Ito T, Abbosh P, Viterbo R, Chen DY, Greenberg RE, Canter D, Smaldone MC, Kutikov A.

Urol Oncol. 2014 Nov;32(8):1267-71. doi: 10.1016/j.urolonc.2014.05.003. Epub 2014 Jun 7.

Supplemental Content

Support Center